Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Berek

Showing results (141-150 of 172) with videos related to

Pageof 18
Sort By:
Gynecologic Oncology|July 1, 1989
Utilization of a murine model to optimize volume and dwell time of intraperitoneal cisplatinR G Pretorius, S Eisenkop, J S Berek, et al.
Gynecologic Oncology|April 1, 1994
Conservative and individualized surgery for early squamous carcinoma of the vulva: the treatment of choice for stage I and II (T1-2N0-1M0) diseaseR Farias-Eisner, F D Cirisano, D Grouse, et al.
Cancer Research|September 1, 1985
Synergistic effects of combination sequential immunotherapies in a murine ovarian cancer modelJ S Berek, A K Lichtenstein, R M Knox, et al.
Medical Care|April 1, 1998
Reducing loss-to-follow-up among women with abnormal Pap smears. Results from a randomized trial testing an intensive follow-up protocol and economic incentivesA C Marcus, C P Kaplan, L A Crane, et al.
Obstetrics and Gynecology|May 1, 1986
CA 125 serum levels correlated with second-look operations among ovarian cancer patientsJ S Berek, R C Knapp, G D Malkasian, et al.
Medical Care|March 1, 1992
Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategiesA C Marcus, L A Crane, C P Kaplan, et al.
Cancer Treatment Reports|December 1, 1983
Pharmacokinetics of Ip cisplatin in refractory ovarian carcinomaR G Pretorius, N F Hacker, J S Berek, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 10, 2006
Progress in ovarian cancer research: proceedings of the 5th Biennial Ovarian Cancer Research SymposiumM L Disis, S E Rivkin, A Baron, et al.
Gynecologic Oncology|June 1, 1983
Estrogen and progesterone receptors in ovarian neoplasmsL C Ford, J S Berek, L D Lagasse, et al.
Obstetrics and Gynecology|November 1, 1984
Lymphocyte cytotoxicity in the peritoneal cavity and blood of patients with ovarian cancerJ S Berek, R C Bast, A Lichtenstein, et al.
Pageof 18

Showing results (141-150 of 172) with videos related to

Sort By:
Pageof 18
Gynecologic Oncology|July 1, 1989
Utilization of a murine model to optimize volume and dwell time of intraperitoneal cisplatinR G Pretorius, S Eisenkop, J S Berek, et al.
Gynecologic Oncology|April 1, 1994
Conservative and individualized surgery for early squamous carcinoma of the vulva: the treatment of choice for stage I and II (T1-2N0-1M0) diseaseR Farias-Eisner, F D Cirisano, D Grouse, et al.
Cancer Research|September 1, 1985
Synergistic effects of combination sequential immunotherapies in a murine ovarian cancer modelJ S Berek, A K Lichtenstein, R M Knox, et al.
Medical Care|April 1, 1998
Reducing loss-to-follow-up among women with abnormal Pap smears. Results from a randomized trial testing an intensive follow-up protocol and economic incentivesA C Marcus, C P Kaplan, L A Crane, et al.
Obstetrics and Gynecology|May 1, 1986
CA 125 serum levels correlated with second-look operations among ovarian cancer patientsJ S Berek, R C Knapp, G D Malkasian, et al.
Medical Care|March 1, 1992
Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategiesA C Marcus, L A Crane, C P Kaplan, et al.
Cancer Treatment Reports|December 1, 1983
Pharmacokinetics of Ip cisplatin in refractory ovarian carcinomaR G Pretorius, N F Hacker, J S Berek, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 10, 2006
Progress in ovarian cancer research: proceedings of the 5th Biennial Ovarian Cancer Research SymposiumM L Disis, S E Rivkin, A Baron, et al.
Gynecologic Oncology|June 1, 1983
Estrogen and progesterone receptors in ovarian neoplasmsL C Ford, J S Berek, L D Lagasse, et al.
Obstetrics and Gynecology|November 1, 1984
Lymphocyte cytotoxicity in the peritoneal cavity and blood of patients with ovarian cancerJ S Berek, R C Bast, A Lichtenstein, et al.
Pageof 18